The understanding of AAV pathogenesis isincreasing, leading to improvements in diagnosisand management of these diseases; however,challenges remain. Further advances in knowledgeof disease processes, improved diagnostic criteriaand the identification of validated biomarkers toassess treatment response and predict relapseshould aid in the development of more precise, personalized treatment. To read the full article : https://rdcu.be/b6uUx